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A subtype of glycohaemoglobin, haemoglobin (Hb) Alc, in
specimens ofwhole blood was assayed on a new automated analyser
that makes use of high-pressure, liquid chromatography. The
analyserprovidedprecise and reproducible values. The mean ofthe
HbAc values was lower than that with an older instrument. The
mean tended to increase with the age of the subjects, who were
undergoing routine health examinations. No sex difference was
found. When measurement was made I h after the subjects drank
50g of glucose, the value ofHbAc was unaffected. Correlation
was strong between the HbAc value and thefasting blood glucose
value, which suggested thatfasting bloodglucose could be estimated
from the HbAc value.
Introduction
There are several methods for the measurement of
haemoglobin Ale (HbAlc) in red blood cells, involving
electrophoresis, colorimetry, minicolumns and high-
pressure liquid chromatography (HPLC). Each method
has different advantages but a problem shared by all of
these is the long testing time.
Here, we evaluate the performance of an automated
apparatus for the assay of HbA1 and HbAI (Hi-Auto
AI, model 8121, Kyoto Daiichi Kagaku Co., Ltd) first
marketed in 1987. In this model, HbAla, HbAlb, HbAI,
and HbF are separated more completely than in the
earlier analyser (model 8120) tested here for comparison,
Table 1. Effects ofanticoagulants on HbAc and AI values (%)
found with models 8120 and 8121.
Anticoagulant Model HbAlc, % HbA1, %
NaF 8120 5.41 + 0-51 8"09 + 0.76
(N 204) 8121 4"92 + 0.44 7"09 + 0.76
EDTA 8120 5" 17 + 0"55 8"05 + 0.81
(N 246) 8121 4"85 + 0"55 6.97 + 0.84
Na-citrate 8120 5"08 + 0’36 8"07 + 0’65
(N 85) 8121 4"78 + 0"38 6"80 + 0"57
Note: Values for each haemoglobin are the mean percentage +
SD of total haemoglobin, found by HPLC.
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because of changes made in the column filler and in the
eluent. In the newer model, unstable HbAI is eluted first
by use of tetrapolyphosphoric acid, which competes for
the site on the haemoglobin molecule where glucose
binds.
Materials and methods
Instruments
The machine tested was a Hi-Auto Alc model 8t21,
which assays HbAc, HbA, and HbF in 4 min with 3 gl
specimens [1]. For comparison, an older model from the
same manufacturer (Hi-Auto A model 8120, which
resembles the model 8110 described in [2]) was used.
Materials
Everyone who comes to our health care centre is a
company employee with no known current health prob-
lems who is to undergo routine health examinations.
Table 2. Day-to-day reproducibility of HbAlc and HbAI and
retention time in assay of control material. The same column was
used to measure about 90 specimens daily for 20 days. Each
specimen was from a different subject. Control material was
assayed once at the end of each work day.
Item
HbAlc, HbA1, Retention Numbers of
Day % % time specimens
6.5 9.5 2’09 90
2 6.4 9.3 2’08 88
3 6.5 9-5 2’06 89
4 6.4 9.3 2’06 90
5 6.5 9.5 2’11 88
6 6.4 9.4 2’09 89
7 6.5 9.5 2’09 91
8 6.4 9"3 2’ 11 90
9 6.5 9"8 2’09 87
10 6.4 9.5 2’06 90
11 6.5 9"5 2’09 88
12 6.4 9"6 2’09 89
13 6.5 9.6 2’09 89
14 6.5 9.5 2’09 88
15 6.4 9.5 2’08 89
16 6"5 9.5 2’06 92
17 6.4 9.5 2’09 90
18 6.5 9"5 2’09 90
19 6.4 9"5 2’12 89
20 6.5 9"5 2’06 90
CV 0.79 1.18 1.37 Total, 1786
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Figure 1. Effects of storage at two temperatures in three different anticoagulants on valuesfoundfor HbAlc and HbA1 with the newer
analyser. (a) Room temperature; (b) 4 oC. (D, NaF; , EDTA; /k, Na-citrate.
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Figure 2. Comparison ofHbAc, HbAh andHbF values measured with the newer analyser in blood of fasting subjects and in blood ofthe
same subjects one hour after glucose intake.
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Tests of urine, stools, blood chemistry and pulmonary
function are carried out, and a complete blood cell count,
X-ray films of the chest and the upper gastrointestinal
tract, and electrocardiographs are taken. Glucose metab-
olism is examined by tests of urinary glucose and fasting
blood glucose (FBG), and by a 50 g oral glucose tolerance
test (OGTT), from which the blood glucose concen-
tration h after the intake ofglucose (postprandial blood
glucose, or PBG) was used here. In the OGTT, blood was
collected into bottles containing NaF when the subject
was fasting and again at h.
Venous blood was withdrawn from the examinees with a
Venoject syringe (Terumo Co., Osaka) containing NaF
(1"25 mg/ml blood), sodium citrate (0"5 ml of a 3"85%
solution per 4"5 ml of blood), or a mixture ofEDTA-2Na
(3’7 mg/ml blood) and heparin (12"5 U/ml blood). The
glycohaemoglobins in the blood were assayed within h
of sampling. Blood glucose was assayed by the neo-
cuproine method [3].
Control material was purchased from International
Reagents Corporation (Kobe).
Statistics
Results were evaluated by Student’s t-test and analysis of
variance.
Results
HbAlc measurements by the new model
The effects of the anticoagulant used on the value of
HbAlc are shown in table 1. The mean values obtained
for HbAlc were highest with NaF, intermediate with
EDTA plus heparin, and lowest with sodium citrate.
Mean values for HbA1 were almost the same with all
three anticoagulants. The newer model gave lower values
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Figure 3. Distribution of HbAc values of 7260 specimens
measured with the newer analyser.
than the older model in assays of both of these
haemoglobins. With NaF, the mean values for HbAc for
the two glycohaemoglobins were significantly different.
The differences probably arose from differences in the
column fillers and in the elution method, which cause
differences in the efficiency of the removal of unstable
glycohaemoglobin. With NaF, the blood glucose value of
the specimens was not lowered as much as with the other
anticoagulants, so that nearly all of the unstable form
remained unbound in the specimens. For these reasons,
the HbAlc values obtained by the older model, in which
removal of the unstable glycohaemoglobin was less
efficient, were higher.
When samples were stored at 4C or room temperature
in one of the three anticoagulants for up to 5 days (figure
1), results for HbAlc stayed about the same. However, at
room temperature, values for HbA increased during
storage.
Table 2 shows the day-to-day reproducibility of HbAlc
andHbA in control material assayed by the newer model
with use of the same column for 20 days. The number of
other specimens measured daily was about 90, each from
a different subject; in all, 1786 specimens were assayed
during these 20 days. Retention time with the HPLC
column did not change. Each day, after all test specimens
were assayed, control material was tested. Correlation
was satisfactory for both glycohaemoglobins. Thus,
repeated use such as is described here did not affect the
results obtained with the column.
Relationship betweeen glycohaemoglobin values and blood glucose
levels
In diabetic subjects, the unstable form ofHbAlc increases
as the glucose level increases but the stable form is
unchanged [4]; the same changes occur in healthy
subjects, as in the OGTT. Thus, total HbAc (stable plus
unstable forms) rises with increasing glucose. In the 69
subjects chosen at random during the test period to
illustrate typical results here, the mean FBG level was 106
+ 17 mg/dl and the PBG level was 161 + 45 mg/dl.
Figure 2 shows the values for each of the three forms of
haemoglobin assayed by the new model, HbA1, stable
HbAlc, and HbF, when the subjects were fasting (x-axis)
and at h after glucose intake (y-axis). Correlation was
satisfactory for all these three forms.
Distribution ofHbAec values in specimens
Figure 3 shows the distribution of HbAlc values in 7260
examinees screened over a 4 month period. The coeffi-
cient of variation (CV) was 5"22% .and the standard
deviation (SD) was 0"70%. The reference interval was
calculated by the method of Hoffman [5]. The mean
reference value and the SD were 5"13% and 0"43%,
respectively.
Table 3 shows mean values of HbAlc measured with the
older model for different age groups and by sex for 5319
subjects. Table 4 shows mean levels ofHbAlc in the same
way, measured with the newer model for 6807 other
subjects. Results in table 4 are based on those in figure 4,
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Table 3. HbAlc values (%) obtained with the older model with subjects classified by age and sex.
Age
Sex -29 30- 40- 50- 60- 70- Mean
Total
number
5"04 5"18 5"31 5"40 5"49 5"52 5’32 Male (0"26)]" (0"35) (0"39) (0"43) (0"46) (0"41) (0"42)
3660
4"88 4"94 5"02 5"24 5"27 5"24 5"08 Female 1659 (0"22) (0’26) (0’28) (0"35) (0"32) (0" 17) (0"34)
4.97 5.10 5.22 5.35 5.43 5.45 5.25 Total (0"26) (0"35) (0"39) (0"42) (0.44) (0"39) (0"42)
5319
Numbers in parentheses represent SD.
Table 4. HbAlc values (%) obtained with the newer model with subjects classified by age and sex.
Age
Sex 29 30- 40- 50- 60- 70- Mean
Total
number
4.93 5.07 5.15 5.24 5.30 5.33 5.18 Male (0"36)]" (0"36) (0"42) (0.45) (0"45) (0.45) (0.44) 4714
4.78 4.91 4.95 5"15 5"25 5.34 5"03 Female 2093 (0"30) (0"33) (0"33) (0"37) (0"41) (0"45) (0"38)
4"87 5"02 5"09 5"21 5"29 5"33 5"13 Total (0"36) (0"36) (0"41) (0’43) (0"44) (0"47) (0"43)
6807
Numbers in parentheses represent SD.
6.0"
,5 5.0-
4.0-
3.0-
Men
Women
T TT TT TT -T T I/ u
FF--TT--]I i il il
29 30-- 40-- 50- 60-- 70-- total
Age, years
Figure 4. HbAc values by age and sex. The values are based on
those in table 4, measured with the newer analyser. Curves connect
the means and bars show 1 SD.
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Figure 5. Correlation between HbAc andfasting blood glucose
(FBG) measured with the newer analyser.
and one SD is shown. The mean values for this one large
group measured with the older model were generally
higher than those of the other large group measured with
the newer model. HbA]c tended to be higher in men than
in women. It also tended to increase with age.
Figure 5 shows the correlation between HbAlc and FBG
in the 7260 specimens of figure 3. The correlation was
high.
Discussion
The clinical significance of glycohaemoglobins has been
established and their assay is becoming routine.
However, the presence of HbF and the instability of
HbA]c [4] interfere with the accurate measurement of
stable HbAlc, which is of clinical interest. The number of
samples sent for testing to clinical laboratories is on the
increase and automation by a more reliable method is
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desirable. The machine we tested separates subfractions
of haemoglobins in an HPLC column at a controlled
temperature, so that measurement is stable and data are
both precise and accurate. The machine removed un-
stable HbAlc and could assay 3 bd samples. The time
taken for a single assay was 4 min; the retention time was
short (table 2). The newer model gave lower values of
HbAlc than the older model, probably because of the
removal of unstable HbAlc by the use of tetrapolyphos-
phoric acid. After blood is sampled, the glucose level
decreases and so the unstable HbAc in the blood changes
gradually to the nonglycosylated HbA form [4]. If
unstable HbAc is not removed before assay, then the
extent ofdecomposition will influence the value obtained
for total HbA
With the newer machine tested here, storage time did not
affect the value obtained forHbA, which value is closely
correlated with the presence ofdiabetes. However, HbA1,
which has less correlation with diabetes, was affected by
storage time and, ifan accurate value forHbA is needed,
specimens should be assayed within 2 days of sampling.
Because HbA is unstable when blood is stored, and
because correlation is good between HbA and HbAlc
levels in blood assayed soon after being sampled, in
general, assay of HbAlc is more likely to give reliable
results. Results for the assay of control material were
highly reproducible (table 2).
The anticoagulants did not affect the level of HbA1 and
HbAc, so any of them can be used when HbAlc is to be
assayed. If the glucose level of the specimen is also to be
measured, NaF can and should be used.
The mean difference in the glucose level when 69 of the
subjects were fasting and h after the intake of 50 g of
glucose was about 50 mg/dl but the levels of HbA1 and
HbAlc were unaffected by this difference.
The reference values for HbA and HbA obtained by
groups using cation-exchange chromatography [6] are
wider than ours, probably because of the removal of
unstable HbAlc by the machine we used. We found that
HbAI tended to increase with the age of our subjects
(aged 22 to 82 years). The same tendency has been
reported for subjects divided into those aged 21 to their
45th birthday and those older. Because both the blood
glucose level and glucose intolerance increase with age
[8], the glycohaemoglobin level can be expected to
increase, so our findings are reasonable. HbAlc is ofuse in
the monitoring of the glucose levels of a subject in the
preceding few months. Because correlation between
HbAlc and FBG is high, the value ofHbAc should also
be ofuse for prediction of the likeliness that a subject will
develop diabetes mellitus.
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